glycoside/aptaukošanās

Saite tiek saglabāta starpliktuvē

Izvēlieties kārtošanas veidu

13 rezultātiem

C-aryl glycoside compounds for the treatment of diabetes and obesity

Rakstu tulkošanu var veikt tikai reģistrēti lietotāji

Ielogoties Reģistrēties

This invention relates to a family of fluorinated C-aryl glycoside compounds, the process for their preparation, as well as the application of same in the pharmaceutical and cosmetics fields, in particular for the treatment of diabetes and obesity. Sugars and the derivatives thereof constitute one

Method for producing C-glycoside derivative and intermediate for synthesis thereof

Rakstu tulkošanu var veikt tikai reģistrēti lietotāji

Ielogoties Reģistrēties

TECHNICAL FIELD The present invention relates to a method for producing a C-glycoside derivative which is useful as a Na.sup.+-glucose cotransporter inhibitor for treating and preventing, in particular, diabetes such as insulin-dependent diabetes (type 1 diabetes), non-insulin-dependent diabetes

Compositions and methods for treating obesity, obesity related disorders and for inhibiting the infectivity of human immunodeficiency virus

Rakstu tulkošanu var veikt tikai reģistrēti lietotāji

Ielogoties Reģistrēties

FIELD OF THE INVENTION The present invention relates generally to methods and compositions for modulating the body weight of mammals including animals and humans, and more particularly to materials identified herein as modulators of weight, and the use of these materials for treating obesity and

Compositions and methods for treating obesity, obesity related disorders and for inhibiting the infectivity of human immunodeficiency virus

Rakstu tulkošanu var veikt tikai reģistrēti lietotāji

Ielogoties Reģistrēties

FIELD OF THE INVENTION Background of the Invention Obesity, which is defined in general terms as an excess of body fat relative to lean body mass, is now a world wide epidemic, and is one of the most serious contributors to increased morbidity and mortality. Obesity is prevalent in the United

Glycoside-hydrolase enzyme inhibitors

Rakstu tulkošanu var veikt tikai reģistrēti lietotāji

Ielogoties Reģistrēties

BACKGROUND OF THE INVENTION Carbohydrates are eaten either as simple sugars or as more complex molecules called polysaccharides, which are built up from simple sugar units and of which the starch of potatoes, bread, etc., is a well-known example. The body absorbs carbohydrates from the small

Glycoside-hydrolase enzyme inhibitors

Rakstu tulkošanu var veikt tikai reģistrēti lietotāji

Ielogoties Reģistrēties

C-glycoside derivatives and salts thereof

Rakstu tulkošanu var veikt tikai reģistrēti lietotāji

Ielogoties Reģistrēties

CROSS REFERENCE TO RELATED APPLICATIONS This application is a national phase application of International Application Number PCT/JP2004/003324, filed Mar. 12, 2004, and claims the priority of Japanese Patent Application No. 2003-070297, filed Mar. 14, 2003, the content of both of which is

C-glycoside derivatives and salts thereof

Rakstu tulkošanu var veikt tikai reģistrēti lietotāji

Ielogoties Reģistrēties

FIELD OF THE INVENTION The present invention relates to C-glycoside derivatives and salts thereof. More particularly, the present invention relates to C-glycoside derivatives and salts thereof useful as a Na+-glucose cotransporter inhibitor. C-glycoside derivatives and salts thereof of the present

Pregnane glycoside compositions and Caralluma extract products and uses thereof

Rakstu tulkošanu var veikt tikai reģistrēti lietotāji

Ielogoties Reģistrēties

BACKGROUND TO THE INVENTION 1. Field of the Invention This invention relates to Caralluma extract, and, more particularly, this invention relates to a treatment and management of obesity and obesity-related symptoms/problems/disorders and other disorders using the Caralluma extracts, to pregnane

Anti-obesity product and its method of preparation

Rakstu tulkošanu var veikt tikai reģistrēti lietotāji

Ielogoties Reģistrēties

TECHNICAL FIELD The present invention relates to compositions comprising one or more anthraquinones for use in the treatment of obesity, metabolic disease, or liver disease. More particularly it relates to a plant extract fraction rich in anthraquinones including both anthraquinone glycosides (major

Anti-obesity product and its method of preparation

Rakstu tulkošanu var veikt tikai reģistrēti lietotāji

Ielogoties Reģistrēties

Methods and compositions for the treatment of obesity, insulin related diseases and hypercholesterolemia

Rakstu tulkošanu var veikt tikai reģistrēti lietotāji

Ielogoties Reģistrēties

BACKGROUND OF THE INVENTION (1) Field of the Invention The present invention relates to the treatment of insulin related diseases, obesity, diabetes mellitus, hyperglycemia, lipid disorders, hyperlipidemia, or low HDL, hypercholesterolemia, hyperglyceridemia, dyslipidemia, and atherosclerosis. The

Amylase inhibitor

Rakstu tulkošanu var veikt tikai reģistrēti lietotāji

Ielogoties Reģistrēties

BACKGROUND OF THE INVENTION It is known that in animals and man, after the intake of starchy foodstuffs and beverages, hyperglycaemias arise which are caused by a rapid splitting of the starch by amylases of the digestive tract according to the following equation: These hyperglycaemias are

Pievienojieties mūsu
facebook lapai

Herbal & Natural Medicine

Vispilnīgākā ārstniecības augu datu bāze, kuru atbalsta zinātne

Darbojas 55 valodās
Zāļu ārstniecības līdzekļi, kurus atbalsta zinātne
Garšaugu atpazīšana pēc attēla
Interaktīva GPS karte - atzīmējiet garšaugus atrašanās vietā (drīzumā)
Lasiet zinātniskās publikācijas, kas saistītas ar jūsu meklēšanu
Meklēt ārstniecības augus pēc to iedarbības
Organizējiet savas intereses un sekojiet līdzi jaunumiem, klīniskajiem izmēģinājumiem un patentiem

Ierakstiet simptomu vai slimību un izlasiet par garšaugiem, kas varētu palīdzēt, ierakstiet zāli un redziet slimības un simptomus, pret kuriem tā tiek lietota.
* Visa informācija ir balstīta uz publicētiem zinātniskiem pētījumiem